Is Piramal Enterprises Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Piramal Enterprises Ltd and arrived at the following conclusion.

Is the current market price of Piramal Enterprises Ltd a good price to buy it?

The 5-year analysis of Piramal Enterprises Ltd's performance infers.

What is Piramal Enterprises Ltd share price return in the past 10 years?

We analysed the performance of Piramal Enterprises Ltd share prices over the last 10 years. Here is what we found out:

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Piramal Enterprises Ltd

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

What is CAGR? What does CAGR table indicate for Piramal Enterprises Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Piramal Enterprises postpones Rs 3,000 crore NCD plan

Piramal Enterprises Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500302 | NSE: PEL

29 Aug 2019

Evaluate

Piramal Enterprises has postponed the issue of privately placed non-convertible debentures (NCDs) aggregating Rs 3,000 crore to a future date. The Administrative Committee of the Board has decided the same.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Related Piramal Enterprises Ltd. Links:

Analysis

Reports

News

Stock Price

Sector News